As-needed ruxolitinib shows successful long-term symptom control in AD Presented ByDr Andrew Blauvelt, Oregon Medical Research Center, OR, USA TrialPhase 3, TRuE-AD1 and TRuE-AD2 ConferenceAAD 2023 15 May, 2023 11:43
Ruxolitinib cream: a safe treatment for elderly AD patients Presented ByProf. Jacek Szepietowksi, Wroclaw Medical University, Poland TrialPhase 3, TRuE-AD1; TRuE-AD2 ConferenceEADV 2021 18 November, 2021 13:21
